Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Case Report

Agomelatine Augmenting Partial Stimulant Response in ADHD and Mitigating Stimulant-induced Insomnia and Anxiety

Ahmed Naguy1*, Ali Al-tajali2

1Child/Adolescent Psychiatrist, Kuwait Centre for Mental Health (KCMH)

2General Adult Psychiatrist, Neuromodulation & Psych Rehab, KCMH

*Corresponding Author:
Ahmed Naguy
Department of Child and Adolescent Psychiatrist
Kuwait Centre for Mental Health (KCMH), Kuwait
Tel: +965/65541937
Email: ahmednagy@hotmail.co.uk

Received Date: April 22, 2015 Accepted Date: May 14, 2015 Published Date: May 21, 2015

Citation: Naguy A, Tajali AA (2015) Agomelatine Augmenting Partial Stimulant Response in ADHD and Mitigating Stimulant-induced Insomnia and Anxiety. J Child Adolesc Behav 3:208. doi:10.4172/2375-4494.1000208

Copyright: © 2015 Naguy A, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Abstract

Attention deficit hyperactivity disorder (ADHD) is amenable to successful pharmacologic treatment with stimulants being first-line. Stimulants are generally safe but could be associated with some adverse effects such as insomnia and anxiety exacerbation in this population, both of which could jeopardize treatment-adherence and blunt the therapeutic response. Here, we are reporting a 13-year-old case of severe ADHD with mediocre response to an adequate trial of methylphenidate with stimulant-related anxiety and insomnia that robustly showed marked cognitive improvement and amelioration of both anxiety and insomnia after augmentation with agomelatine with great safety and tolerability.

Keywords

Top